Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: efficacy and safety of denosumab.
about
Development and evaluation of an algorithm to identify users of Prolia(®) during the early postmarketing period using health insurance claims data.Assessment of off-label use of denosumab 60 mg injection during the early postmarketing period using health insurance claims data.The best of both worlds - managing the cancer, saving the bone.Skeletal manifestations of treatment of breast cancer.Adjuvant Endocrine Therapy and Bone Health in Breast Cancer.The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation.Cancer Treatment and Bone Health.
P2860
Q30837986-52EDC7CA-723D-41B8-8F6A-2E93064D0C7BQ31021577-B6089F4B-F86F-42FD-AF6F-014B817E837DQ33920055-D7E98A8E-569B-46B3-888F-96443E34183DQ37630298-BA17ACC4-8BB5-4835-B3FB-AFEE72FF86DEQ38553766-159FD742-F080-46FC-BEBD-7E6268788264Q47138098-13C93A06-EAAE-4DBB-87AE-F0CAB65F89EEQ49211720-07EEE1DA-D064-4797-976C-B8C23589FBD7
P2860
Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: efficacy and safety of denosumab.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Treatment-induced bone loss an ...... icacy and safety of denosumab.
@ast
Treatment-induced bone loss an ...... icacy and safety of denosumab.
@en
type
label
Treatment-induced bone loss an ...... icacy and safety of denosumab.
@ast
Treatment-induced bone loss an ...... icacy and safety of denosumab.
@en
prefLabel
Treatment-induced bone loss an ...... icacy and safety of denosumab.
@ast
Treatment-induced bone loss an ...... icacy and safety of denosumab.
@en
P2093
P2860
P356
P1476
Treatment-induced bone loss an ...... icacy and safety of denosumab.
@en
P2093
Allan Lipton
Carsten Goessl
Georgiana K Ellis
Matthew R Smith
P2860
P304
P356
10.4137/CMO.S8511
P407
P577
2012-08-16T00:00:00Z